Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Diovan/Co-Diovan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Diovan/Co-Diovan was produced by Novartis.

It’s only money

It’s only money

It is suspected that falsified data was used in the clinical trial of Novartis’s best selling drug Diovan.

Novartis sales dip, but all eyes are on Entresto

Novartis sales dip, but all eyes are on Entresto pressure drug Diovan (valsartan) and other products such as its oestrogen patch Vivelle-Dot.

Novartis heart drug may see novel pricing plan

Novartis heart drug may see novel pricing plan The drug, which combines its now off patent blood pressure drug Diovan (valsartan) and a new antihypertensive drug sacubitril, is set for approval in August for patients with heart failure.

Heart drug sales continue downward spiral

Heart drug sales continue downward spiral Novartis has been one of the hardest hit in recent years with the patent losses of its blood pressure drug Diovan (valsartan), which was making $6bn in sales a year at

Novartis still hungry after absorbing GSK oncology

Novartis still hungry after absorbing GSK oncology The company is now starting to recover from patent expirations on former top brands such as Diovan (valsartan) for high blood pressure and combination follow-up Exforge (valsartan and amlodipine), with

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics